| Code: MTA12503 | Publication Date: May 2026 |
The Vietnam ADHD Medication Market is rapidly growing, due to longstanding presence of local pharmaceutical giants and global organizations. Some of the key players in the market include Janssen Vietnam, Novartis Vietnam, Takeda Vietnam, and Viatris Vietnam.
According to 6Wresearch, the Vietnam ADHD Medication Market is expected to show a significant growth, owing to the rapidly aging population, along with rising prevalence of metabolic syndromes. The growing occurrence of adult ADHD and paediatric diagnoses increases the demand for a broad range of pharmacological treatments. Additionally, improved healthcare infrastructure and increasing consumer awareness about mental health are driving innovation in advanced therapies, like non-invasive nerve stimulation, and next-generation pain management solutions.
The competitive landscape of the Vietnam ADHD medication industry is driven by biotech investment and strategic global partnerships. The market witnesses a strong competition between global giants and domestic players, that offer a variety of ADHD medications, such as nerve supplements and sophisticated prescription grade anaesthetics.
Below is a list of leading players operating in the Vietnam ADHD Medication Market:
| Company Name | Janssen Vietnam |
|---|---|
| Established Year | 1953 (Global) / 1990s (Vietnam Presence) |
| Headquarters | Beerse, Belgium (Global) / Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Janssen Vietnam is a dominant leader in the ADHD space, providing Concerta, which is essential for treating ADHD in paediatric and adult patients.
| Company Name | Novartis Vietnam |
|---|---|
| Established Year | 1996 (Merger) |
| Headquarters | Basel, Switzerland (Global) / Ho Chi Minh City, Vietnam |
| Official Website | - |
Novartis Vietnam is a global powerhouse known for its R&D in central nervous system therapies, offering high-quality methylphenidate formulations.
| Company Name | Takeda Vietnam |
|---|---|
| Established Year | 1781 (Global) / 2012 (Representative Office) |
| Headquarters | Tokyo, Japan (Global) / Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Takeda Vietnam maintains a strong presence with its specialized CNS portfolio, focusing on the introduction of long-acting stimulant treatments.
| Company Name | Viatris Vietnam |
|---|---|
| Established Year | 2020 (Global/Vietnam Launch) |
| Headquarters | Canonsburg, USA (Global) / Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Viatris Vietnam contributes to the market with a robust portfolio of neuroprotective agents and specialized generic medications.
| Company Name | Savipharm (Sa Gon Pharmaceutical Joint Stock Company) |
|---|---|
| Established Year | 2005 |
| Headquarters | Ho Chi Minh City, Vietnam |
| Official Website | - |
The Savipharm brand focuses on innovative biological treatments and supportive over-the-counter nerve health solutions that cater to the growing population.
| Company Name | GSK Vietnam |
|---|---|
| Established Year | 1715 (Global) / 1994 (Vietnam Presence) |
| Headquarters | London, UK (Global) / Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
GSK Vietnam is a leader in CNS research, developing next-generation therapies through strategic alliances with global innovators for neurological and behavioural health.
| Company Name | Pfizer Vietnam |
|---|---|
| Established Year | 1849 (Global) / 1994 (Vietnam Presence) |
| Headquarters | New York, USA (Global) / Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Pfizer Vietnam contributes to the market with its established portfolio of metabolic and CNS medications, managing the underlying comorbidities often associated with ADHD.
| Company Name | Sanofi Vietnam |
|---|---|
| Established Year | 1973 (Global) / 1960s (Vietnam Presence) |
| Headquarters | Paris, France (Global) / Ho Chi Minh City, Vietnam |
| Official Website | Click Here |
Sanofi Vietnam is highly specialized in neurology, providing localized pharmacological solutions and R&D for neuro-psychiatric treatment advancement.
| Company Name | Boehringer Ingelheim Vietnam |
|---|---|
| Established Year | 1885 (Global) / 1998 (Vietnam Presence) |
| Headquarters | Ingelheim, Germany (Global) / Ho Chi Minh City, Vietnam |
| Official Website | - |
Boehringer Ingelheim Vietnam provides specialized treatments for underlying neurological pathways and continues to invest in pharmaceutical innovation.
| Company Name | Pymepharco |
|---|---|
| Established Year | 1989 |
| Headquarters | Tuy Hoa, Phu Yen, Vietnam |
| Official Website | Click Here |
Pymepharco is a rapidly growing player in the CNS segment, offering cost-effective therapeutic options for patients managing ADHD.